Rekha Chandran

ORCID: 0000-0003-1566-0864
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Colorectal and Anal Carcinomas
  • Hematopoietic Stem Cell Transplantation
  • Glycosylation and Glycoproteins Research
  • Cancer and Skin Lesions
  • Immune Cell Function and Interaction
  • Toxin Mechanisms and Immunotoxins
  • T-cell and B-cell Immunology
  • Blood disorders and treatments
  • Gastric Cancer Management and Outcomes
  • Neurofibromatosis and Schwannoma Cases
  • Vascular Malformations and Hemangiomas
  • Single-cell and spatial transcriptomics
  • Sleep and Work-Related Fatigue
  • Neutropenia and Cancer Infections
  • Fungal Infections and Studies
  • Skin Diseases and Diabetes
  • Genetic and rare skin diseases.
  • Occupational Health and Performance
  • Healthcare Policy and Management
  • Genetic factors in colorectal cancer
  • Multiple Myeloma Research and Treatments
  • Ergonomics and Musculoskeletal Disorders
  • Mast cells and histamine

Medical College of Wisconsin
2013-2015

Legacy Health
2012-2013

Queen's University Belfast
1995

to the plug formation.This inflammation then leads fibrosis and atrophy. 4It may be that TGF-β signaling also involved because it is known plays an important role in wound healing scar formation.In LDS, atrophic scars delayed have been reported. 5Interestingly, TGFBR1 null mutations cause multiple self-healing squamous epithelioma (MSSE) 6 with subsequent scarring, which typical for AV.However, patients MSSE do not features of usually caused by missense TGFBR1-or TGFBR2-kinase domain....

10.1001/jamadermatol.2014.5622 article EN JAMA Dermatology 2015-03-11

Abstract A retrospective study was conducted of 49 patients with primary gastrointestinal lymphoma to analyze clinicopathological features, prognostic factors, and results treatment. Intestinal lymphomas (63%) were more common than gastric (29%). Endoscopic biopsy diagnostic in 64% lymphomas, while 97% intestinal required laparotomy for diagnosis. Lymphoblastic (35%) diffuse large cell (33%) the most frequent histologic types. Complete remission (CR) achieved 61% patients, a 5‐year survival...

10.1002/jso.2930600109 article EN Journal of Surgical Oncology 1995-09-01

The simultaneous presentation of the Hodgkin lymphoma and multiple myeloma in absence prior chemotherapy or radiation is very rare. Here, we discuss a 72-year-old patient who initially presented with generalized pruritis. Workup led to diagnosis which progressed required treatment. As part his pretreatment workup, an MRI was performed evaluate skeletal lesions. This revealed diffuse bulky adenopathy confirmed by PET. A biopsy axillary node consistent nodular sclerosing type lymphoma. He...

10.1155/2013/398769 article EN cc-by Case Reports in Hematology 2013-01-01

A retrospective analysis was done using the Surveillance, Epidemiology, and End-Results (SEER) database to determine trends in overall survival identify prognostic factors patients with mantle cell lymphoma (MCL). In total 5367 cases of MCL identified from 1992 2007 were split into three cohorts, group 1(1992–1999), 2 (2000–2003) 3 (2004–2007). Survival analyzed Cox proportional hazards model correct for age, gender stage disease. The proportion advanced disease at diagnosis, male age...

10.3109/10428194.2012.656628 article EN Leukemia & lymphoma/Leukemia and lymphoma 2012-01-13

We have previously shown that lymphopenia and monocytopenia at 2-3 months post-allogeneic haematopoietic cell transplant (HCT) is associated with poor survival in recipients of both myeloablative reduced intensity conditioning regimens. It not known whether the graft leukocyte content has a role early lymphocyte monocyte recovery following allogeneic T-cell replete peripheral blood HCT.Haematologic data, including absolute counts (ALC AMC, respectively) day +15, +30, +60, +100, outcomes data...

10.1186/2052-1839-14-14 article EN cc-by BMC Hematology 2014-09-01
Coming Soon ...